🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

youtube.com/watch?v=SjwzLx… 🚨 Registrations are OPEN! 🚨 Join us at the 20th Anniversary of the New Orleans Summer Cancer Meeting | NOSCM, where we’ll explore the latest innovations and breakthroughs in oncology! Register NOW at 👉 noscm.com Edgardo S. Santos, M.D., FACP, FASCO Dr. Luis E. Raez

#lungcancer #LCSM

State of the art for #EGFR Econ 20 from Dr. Noemi Reguart at #ITCD2025. Not all mutations are the same here! PAPILLON established amivantamab + chemo as our 1L standard. But TKIs hoping to make an impact.

Nice panel talks and discussions this afternoon addressing ALK, ROS, RET, NTRK & BRAF Jair Bar Stephen V Liu, MD JessicaJLinMD Dr. Antonio Calles 🫁🚭 in Canaria’s Auditorium #itcd2025

Dr. Rafal Dziadziuszko at #ITCD2025 explains the role of radiation in early stage NSCLC - concurrent CRT optimizes local control but remember RT quality matters. When combining drugs with radiation, understand why you’re combining.

Dr. prof Joachim Aerts offers a prediction on the future of 1L immunotherapy for NSCLC at #ITCD2025. Excitement about bispecific antibiotics including ivonescimab. Will cancer vaccines make an impact here?

Join us at La Isla del Encanto for this great and unique CME/CE event. Visit meccinc.com for more information. The 3-day event will start on February 28-March 2, 2025 in Rio Grande, Puerto Rico at the Grand Wyndham Hotel.

Congratulations to our newly elected officers of ISLB. Happy to see so many new XX chromosomes.

#TTLC25 Great to see Edgardo S. Santos, M.D., FACP, FASCO and Katie Scilla U Maryland chairing the first Targeted Therapy session on EGFR, MET HER2/3 #lcsm IASLC

Dr Xiuning Le MD PhD provides a great discussion as to the classification/optimal treatment of EGFR PACC mutations While we can argue as to what is best choice for a pt w EGFR PACC mutation+ NSCLC - there is NO argument that the @iaslc TTLC faculty/staff is the best wolf pack to be

🌟 The 14th Annual Winter Cancer Symposium is almost here, and we’re excited to share a sneak peek of the program! 🎓 Don’t miss out the agenda, packed with cutting-edge research, expert discussions, and much more! Register now at wintercancersymposium.com

After a long weekend of scientific data, discussions, debates, and advances in lung cancer at IASLC TTLC25... back to reality. Go back to work, but at least in this paradise and gorgeous view of Huntington Beach. Relaxation time. Edgardo Santos, MD, FACP, FASCO Lilibeth Castillero FLASCO IASLC

With Dr. Dov Pickholtz, the 14th annual WCS started at Rio Grande, Puerto Rico. Going deeper on the different types of cannabinoids and their receptors. The Medical Educator Consortium Dr. Luis E. Raez Edgardo Santos, MD, FACP, FASCO FLASCO Louisiana Oncology Society The Oncology Institute ASCO ACP Dr Dov Pickholtz

🌟 Day 1 at the Masters in Therapeutic Oncology Summit | MaTOS GU Edition 2025 🌟 We just wrapped up Session 1, and what an amazing start! 🙌 We had the honor of interviewing Dr. Alan Tan, who delivered an incredible presentation💡 #MaTOSGU2025 youtube.com/shorts/Z6o8CpV…

Discussing Cancer and Social Determinants of Health during the 2025 MATOS GU conference with Karine Tawagi MD Amanda Nizam, MD Yaw Nyame Petros Grivas 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Edgardo S. Santos, M.D., FACP, FASCO The Medical Educator Consortium

🌟 Day 1 at the Masters in Therapeutic Oncology Summit | MaTOS GU Edition 2025 🌟 Session 1 just wrapped up, and what an insightful start to the summit! 🙌 We had the privilege of interviewing Dr. Arnab Basu👨‍⚕️ #MaTOS2025 #OncologyExperts #NGSTesting Arnab Basu Edgardo S. Santos, M.D., FACP, FASCO

FLASCO Spring Session Board Meeting going on now discussing exciting educational programs and policies to improve cancer care in Florida.

Fabulous presentations and discussions on EGFRm NSCLC to kick off TLC Conference #TexasLung25!

An amazing discussion on MRD in clinical practice between the panel and Hossein Borghaei, DO to understand the setting for which we could consider using plasma or tissue informed assays. Christine Lovly, MD, PhD, FASCO David Gandara Wade Iams Sandip Patel MD FASCO Christian Rolfo TLC Conference #TexasLung25

#lungcancer #LCSM